GSS.ASX: 1H FY25 Market Update

1H FY25 Market Update

Stock	Genetic Signatures Ltd (GSS.ASX)
Release Time	26 Feb 2025, 10:14 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Genetic Signatures Ltd Reports 1H FY25 Market Update

Key Points

Targeting 2.2M tests across 4 key segments
Potential total addressable market (TAM) of 5.5M tests
Pursuing growth opportunities in high-volume labs and other segments

Full Summary

Genetic Signatures Ltd, a leading provider of molecular diagnostic solutions, has released its 1H FY25 market update. The company is targeting 2.2M tests across 4 key segments, which represent 50%, 32%, 12%, and 6% of the potential total addressable market (TAM) of 5.5M tests. The high-volume LabCorp/Quest segment accounts for over 1,500 tests per day, while other segments range from 100-300 tests per day. Genetic Signatures is pursuing growth opportunities in these high-volume labs as well as in the other segments, which include GI parasite testing requirements and low to medium-volume labs. The company is leveraging its market insights and industry partnerships to drive this growth strategy and capitalize on the expanding diagnostic testing market.